IPF Summit

In the 8th iteration of the event, The ILD Summit and IPF Summit are being combined to foster a unified platform, facilitating deeper insights, collaborative discussions, and innovative solutions that address the common threads and distinct nuances n the pursuit of propelling innovative and efficacious pulmonary fibrosis therapeutics through Phase II and beyond.

This inclusive gathering unites individuals from across the drug development cycle including discovery, preclinical research, translational, biomarker, clinical, regulatory, and patient recruitment, all united in a collective effort to propel innovative and efficacious pulmonary fibrosis therapeutics through Phase II and phase III to patients in need.

Latest Features